Using a large multi-site dataset comprising 1,660 patients with major depressive disorder (MDD) and 1,340 healthy controls (HCs), researchers identified group-level differences in functional ...
In a recent study published in the Scientific Reports, a group of researchers evaluated the efficiency, therapeutic efficacy, and patient perceptions of a custom robotic system for transcranial ...
Nearly a decade after reeling in the first FDA nod allowing its deep brain stimulation technology to help treat major depressive disorder, BrainsWay has doubled back with another agency-cleared ...
Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback